CDH2 and gastric cancer: The WB analyses indicated that the levels of N-cadherin and vimentin were lower in the PA-treated human gastric cancer cells than in the BSA-treated cells, and the decreases occurred after treatment with 75–150 μM of PA for 24 h (Figure 4D) or 150 μM of PA for 12–24 h (Figure 4E).